Pediatrics Group Lays Out Priorities For User Fee Reauthorization

The American Academy of Pediatrics laid out priorities for user fee reauthorization that would expand on the Pediatric Research Equity Act (PREA) and the Best Pharmaceuticals for Children Act (BPCA), including making permanent the BPCA's National Institutes of Health program that funds studies on use of off-patent drugs in children. The group also wants to ensure pediatric studies are completed in a timely manner, make sure drug sponsors plan pediatric studies earlier, increase transparency of studies conducted under BPCA and...